GLPwatch

The mechanism of glucagon-like peptide-1 participation in the osmotic homeostasis.

Dokl Biol Sci · 2016

Last updated 2026-05-28

In rats, the GLP-1 drug exenatide increased the removal of excess water from the body by reducing fluid reabsorption in the kidneys and speeding up the recovery of normal fluid balance. Blocking GLP-1 receptors slowed down this process, showing that GLP-1 plays a key role in managing water and sodium levels.

AI summary of the abstract below.

JournalDokl Biol Sci, 2016
Citations2
Relative citation ratio0.09
NIH percentile7
Molecules

Abstract

We have found the physiological mechanism of intensification of the excessive fluid removal from the body under the action of glucagon-like peptide-1 and its analog exenatide. Under the water load in rats, exenatide significantly increased the clearance of lithium, reduced fluid reabsorption in the proximal tubule of the nephron and intensified reabsorption of sodium ions in the distal parts, which contributed to the formation of sodium-free water and faster recovery of osmotic homeostasis. Blocking this pathway with a selective antagonist of glucagon-like peptide-1 receptors slowed down the elimination of excessive water from the body.

Verbatim abstract via PubMed 27595820 ↗